OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Curcumol Enhances the Antitumor Effect of Lenvatinib on Hepatocellular Carcinoma Cells
ZhaoLi Wu, Jia Wang
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 199-199
Open Access | Times Cited: 8
ZhaoLi Wu, Jia Wang
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 199-199
Open Access | Times Cited: 8
Showing 8 citing articles:
Regulatory Mechanisms of Signaling Pathways in Liver Cancer Treatment with Traditional Chinese Medicine
Shihao Zheng, Tianyu Xue, Chengyuan Xue, et al.
Journal of Ethnopharmacology (2025), pp. 119386-119386
Closed Access
Shihao Zheng, Tianyu Xue, Chengyuan Xue, et al.
Journal of Ethnopharmacology (2025), pp. 119386-119386
Closed Access
DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma
Zhongyan Zhang, Qi Zhou, Zhenchong Li, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101224-101224
Closed Access
Zhongyan Zhang, Qi Zhou, Zhenchong Li, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101224-101224
Closed Access
Biomimetic Co‐delivery of Lenvatinib and FePt Nanoparticles for Enhanced Ferroptosis/Apoptosis Treatment of Hepatocellular Carcinoma
Feichao Xuan, Xingyang Zhao, Weiran Pang, et al.
Advanced Healthcare Materials (2025)
Open Access
Feichao Xuan, Xingyang Zhao, Weiran Pang, et al.
Advanced Healthcare Materials (2025)
Open Access
Modulation of the ubiquitin-proteasome system by curcumin: therapeutic implications in cancer
Shima Yahoo Torghabe, Parisa Alavi, Sara Rostami, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155741-155741
Closed Access
Shima Yahoo Torghabe, Parisa Alavi, Sara Rostami, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155741-155741
Closed Access
Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Yuhang Chen, Shengyuan Dai, Chien‐shan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access
Yuhang Chen, Shengyuan Dai, Chien‐shan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access
Recent advancements in improving the efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy for hepatocellular carcinoma
Tuo Ren, Y. B. Huang
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Tuo Ren, Y. B. Huang
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Exploring a new chapter in traditional Chinese medicine: The potential of Calculus bovis in liver cancer treatment
Hewei Du, Hongbin Chen, Yu Zhao
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 12, pp. 1520-1527
Closed Access
Hewei Du, Hongbin Chen, Yu Zhao
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 12, pp. 1520-1527
Closed Access
Chimeric Antigen Receptor (CAR)‐T Cells: A New Era for Hepatocellular Carcinoma Treatment
Ming Xu, Pan Yang
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 12
Closed Access
Ming Xu, Pan Yang
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 12
Closed Access
